Equities

ICAD Inc

ICAD:NAQ

ICAD Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.49
  • Today's Change-0.075 / -4.81%
  • Shares traded61.27k
  • 1 Year change+3.85%
  • Beta1.3402
Data delayed at least 15 minutes, as of Apr 25 2024 16:50 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

iCAD, Inc. is a global medical technology company, which provides cancer detection and therapy solutions. The Company is focused on providing breast cancer detection solutions built on artificial intelligence (AI) that empowers radiologists to find cancers. Its solutions include advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier, and a range of high-performance, AI and computer-aided detection (CAD) systems and workflow solutions for 2D and 3D mammography, magnetic resonance imaging and computed tomography (CT). The Company’s Breast AI Suite offers a triple threat of clinically proven cancer detection, density assessment, and risk evaluation solutions, designed to accelerate discovery and improve outcomes. It also offers ProFound AI, a digital breast tomosynthesis (DBT) cancer detection and workflow solution.

  • Revenue in USD (TTM)17.32m
  • Net income in USD-7.01m
  • Incorporated1984
  • Employees67.00
  • Location
    ICAD Inc98 Spit Brook Rd Ste 100NASHUA 03062-5737United StatesUSA
  • Phone+1 (603) 882-5200
  • Fax+1 (603) 880-3843
  • Websitehttps://www.icadmed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Precision Optics Corporation Inc19.22m-1.72m33.77m84.00--2.98--1.76-0.289-0.2893.271.871.094.315.09228,782.90-9.77-6.71-13.54-10.5533.3533.65-8.94-5.021.10-10.390.1823--34.2339.1284.42--19.39--
Co-Diagnostics Inc6.81m-35.33m35.64m155.00--0.4143--5.23-1.20-1.200.23212.750.06241.203.6343,948.71-32.365.77-33.856.1538.5782.24-518.6810.9410.52--0.000.00-80.09179.54-148.15--101.27--
LENSAR Inc42.16m-14.38m37.15m130.00--1.10--0.881-1.34-1.343.774.160.67231.547.65324,338.50-22.93-30.97-28.10-36.9450.0651.04-34.11-52.302.64--0.00--19.2511.5727.77---42.91--
BioRegenx Inc22.24k-571.17k38.27m10.00------1,720.56-0.0021-0.00210.00008-0.00080.4899----2,224.00-1,258.22------96.85---2,568.21-----13.2366.29---47.25---629.37------
SeaStar Medical Holding Corp0.00-26.23m38.35m12.00---------1.28-1.280.00-0.29130.00----0.00-800.85-----------------26.51---------115.19------
Cutera Inc212.37m-150.83m39.12m540.00------0.1842-7.57-7.5710.68-8.010.48482.424.78---34.43-20.98-43.99-29.2128.4549.47-71.02-26.072.44-46.541.62---15.865.47-83.18--86.13--
iCAD Inc17.32m-7.01m41.40m67.00--1.23--2.39-0.2742-0.19250.67471.270.37190.80342.16258,477.60-15.06-23.94-19.23-34.1485.3776.96-40.48-45.024.26--0.00---12.54-7.5329.32--23.88--
Milestone Scientific Inc9.83m-6.93m42.82m17.00--5.29--4.36-0.0949-0.09490.13460.10560.78390.851419.53578,085.30-55.68-55.48-73.81-74.7269.1363.97-71.04-88.942.21--0.0013--11.600.423320.41---7.99--
InspireMD Inc6.21m-19.92m43.39m65.00--1.02--6.99-1.08-1.080.25651.810.17172.364.3795,461.54-55.10-60.59-65.08-72.9729.1220.46-320.97-334.786.99--0.00--20.0011.50-7.71--41.57--
DarioHealth Corp20.35m-63.51m44.16m276.00--0.7015--2.17-2.24-2.240.71742.140.18882.214.2573,739.13-55.13-73.26-64.69-87.5929.4029.54-292.00-293.543.38--0.3293---26.4122.450.5091--52.42--
Cytosorbents Corp36.35m-28.51m44.62m186.00--1.91--1.23-0.6375-0.63750.81320.42910.62413.916.20195,426.80-48.94-36.00-61.82-43.5261.6068.15-78.43-62.711.51--0.1781--4.7910.0613.12---9.24--
Vivos Inc19.50k-2.89m46.06m10.00--33.81--2,362.18-0.0079-0.00790.000050.00350.0116--2.17---172.67-202.25-191.32-552.77-30.9710.79-14,844.92-11,969.07----0.00---46.58---17.19------
Vaso Corp81.02m4.81m47.34m300.009.001.768.160.58420.030.030.46260.15311.1020.686.03270,080.006.527.6011.1916.6262.4458.395.935.821.45--0.0043--2.181.84-57.46---22.33--
United Health Products Inc0.00-2.62m47.54m6.00---------0.011-0.0110.00-0.0070.000.00--0.00-826.01-6,446.86------53.19---132,561.200.0606-20.88-----100.00---55.45------
IRIDEX Corp51.87m-9.57m47.78m111.00--5.02--0.9212-0.5934-0.59343.220.58591.352.938.01467,288.30-24.95-19.54-37.31-27.4642.0442.67-18.45-15.451.35--0.00---8.964.02-26.81---24.35--
Data as of Apr 25 2024. Currency figures normalised to ICAD Inc's reporting currency: US Dollar USD

Institutional shareholders

20.26%Per cent of shares held by top holders
HolderShares% Held
Portolan Capital Management LLCas of 31 Dec 20231.23m4.68%
The Vanguard Group, Inc.as of 31 Dec 20231.08m4.10%
First Eagle Investment Management LLCas of 31 Dec 2023679.53k2.58%
Renaissance Technologies LLCas of 31 Dec 2023522.19k1.98%
Granahan Investment Management, LLCas of 31 Dec 2023426.41k1.62%
BlackRock Fund Advisorsas of 31 Dec 2023344.20k1.31%
Greenwood Capital Associates LLCas of 31 Dec 2023322.69k1.22%
PSM Verm�gensverwaltung GmbH Langen v.d.Goltz, Dr. Prinzas of 31 Dec 2023292.62k1.11%
Geode Capital Management LLCas of 31 Dec 2023239.38k0.91%
General American Investors Co., Inc. (Investment Management)as of 31 Dec 2023200.43k0.76%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.